| Allison Leigh Ruzbarsky Yingling, MD | |
|
1850 E Park Ave, Suite 105, State College, PA 16803-6706 | |
| (814) 231-3147 | |
| (814) 231-7351 |
| Full Name | Allison Leigh Ruzbarsky Yingling |
|---|---|
| Gender | Female |
| Speciality | Diagnostic Radiology |
| Experience | 17 Years |
| Location | 1850 E Park Ave, State College, Pennsylvania |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1689882631 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2085R0202X | Radiology - Diagnostic Radiology | MD448171 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Mount Nittany Medical Center | State college, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Mount Nittany Medical Center Health Services Inc | 8426136797 | 196 |
News Archive
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
Paul Farmer, the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was selected as the winner of the 2020 Berggruen Prize for Philosophy and Culture.
The American Heart Association (AHA) is investing nearly $17 million in scientific research to be led by scientists from Boston University, the Ohio State University and Yale University to study the health impacts of e-cigarettes and other nicotine delivery systems on youth and young adults.
› Verified 3 days ago
| Entity Name | Mount Nittany Medical Center Health Services Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1164691499 PECOS PAC ID: 8426136797 Enrollment ID: O20081021000240 |
News Archive
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
Paul Farmer, the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was selected as the winner of the 2020 Berggruen Prize for Philosophy and Culture.
The American Heart Association (AHA) is investing nearly $17 million in scientific research to be led by scientists from Boston University, the Ohio State University and Yale University to study the health impacts of e-cigarettes and other nicotine delivery systems on youth and young adults.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Allison Leigh Ruzbarsky Yingling, MD 1850 E Park Ave, Suite 105, State College, PA 16803-6706 Ph: (814) 231-3147 | Allison Leigh Ruzbarsky Yingling, MD 1850 E Park Ave, Suite 105, State College, PA 16803-6706 Ph: (814) 231-3147 |
News Archive
Genocea Biosciences, Inc., a clinical-stage company pioneering novel T cell vaccines, announced today that it has initiated a Phase 1 study of GEN-004, an investigational vaccine candidate for pneumococcus (Streptococcus pneumoniae), a major cause of infectious disease-related death globally. GEN-004 is the first vaccine candidate designed to prevent infections caused by all strains of pneumococcus through a novel T cell-mediated mechanism of action.
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of events they experienced after radiation than to remember pre-treatment happenings, according to a Baylor University study comparing them to children with healthy brains.
Research & Diagnostic Antibodies LLC (R&D Antibodies) announced today that it has received a notification stating that the European Patent Office intends to grant a patent for its monoclonal antibody-based immunoassays and apparatuses for measuring inducible nitric oxide synthase (iNOS) as a plasma biomarker for the early detection of the sepsis pathology.
Paul Farmer, the Kolokotrones University Professor and chair of the Department of Global Health and Social Medicine in the Blavatnik Institute at Harvard Medical School, was selected as the winner of the 2020 Berggruen Prize for Philosophy and Culture.
The American Heart Association (AHA) is investing nearly $17 million in scientific research to be led by scientists from Boston University, the Ohio State University and Yale University to study the health impacts of e-cigarettes and other nicotine delivery systems on youth and young adults.
› Verified 3 days ago
Dr. Mary Ellen Fisher, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-231-7000 Fax: 814-234-6795 | |
Jerome D. Derdel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6726 Fax: 814-234-1553 | |
Dr. Ari Reuben Geselowitz, MD Radiology Medicare: Medicare Enrolled Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6137 Fax: 814-234-6795 | |
Anna C Hood, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1850 E Park Ave, Suite 105, State College, PA 16803 Phone: 814-231-3147 Fax: 814-231-7351 | |
Veeral B. Patel, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6726 Fax: 814-234-1553 | |
Dr. Paul Benjamin Stoddard, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-231-7000 | |
Dr. Gregory Ross Weimer, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 1800 E Park Ave, State College, PA 16803 Phone: 814-234-6137 Fax: 814-234-6795 |